Intranasal budesonide for rhinitis during a high airborne pollution period: a randomized controlled trial

布地奈德 医学 安慰剂 随机对照试验 临床终点 鼻喷雾剂 鼻子 内科学 鼻腔给药 哮喘 外科 病理 免疫学 替代医学
作者
Yuan Zhang,Chunguang Shan,Weiwei Liu,Yaozhong Han,Guanggang Shi,Yongjian Ma,Kerstin Wagner,Xiaoyan Tian,Lili Zhang,Allan Joseph Larona,Steven Sacavage,Kathleen Franklin,Chengshuo Wang,Luo Zhang
出处
期刊:Allergy, Asthma & Clinical Immunology [BioMed Central]
卷期号:18 (1) 被引量:4
标识
DOI:10.1186/s13223-022-00686-y
摘要

Abstract Background Air pollution may induce or reinforce nasal inflammation regardless of allergy status. There is limited direct clinical evidence informing the treatment of airborne pollution-related rhinitis. Objective To assess the effectiveness of intranasal budesonide in adults with self-reported rhinitis symptoms triggered/worsened by airborne pollution. Methods Adults in northern China with self-reported rhinitis symptoms triggered or worsened by airborne pollution were randomized to budesonide 256 µg/day or placebo for 10 days in pollution season (October 2019 to February 2020). The primary endpoint was the mean change from baseline in 24-h reflective total nasal symptom score (rTNSS) averaged over 10 days. The secondary endpoints were subject-assessed Global Impression of Change (SGIC), mean change from baseline in individual nasal symptom severity, and mean change from baseline in individual non-nasal symptoms of cough and postnasal drip severity. One-sided P < 0.0125 was considered statistically significant. Results After an interruption by COVID-19, an interim analysis showed that the study could be ended for efficacy with n = 206 participants (103/group) since the primary efficacy endpoint demonstrated significant results. The final efficacy results showed that the 10-day-averaged rTNSS change in the budesonide group was greater than with placebo (− 2.20 vs − 1.72, P = 0.0107). Budesonide also significantly improved 10-day-averaged itching/sneezing change (− 0.75 vs − 0.51, P = 0.0009). Results for SGIC and all other individual symptoms did not show significant differences between the two groups. Conclusions Intranasal budesonide 256 µg once daily improved the total nasal symptoms and itching/sneezing over 10 days in adults with rhinitis triggered/worsened by airborne pollution.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
2秒前
充电宝的应助被浅唱夏末采纳,获得10
2秒前
wy.he的应助被车访枫采纳,获得10
2秒前
lyc完成签到,获得积分10
3秒前
HEGONG完成签到,获得积分10
4秒前
忧郁的妙梦完成签到,获得积分10
4秒前
Xue完成签到,获得积分10
4秒前
NexusExplorer的应助被柚子眲采纳,获得10
4秒前
胡玉娇完成签到,获得积分10
6秒前
6秒前
bubi完成签到,获得积分10
6秒前
简单的元珊完成签到,获得积分0
8秒前
wjl完成签到,获得积分10
8秒前
8秒前
歪歪关注了科研通微信公众号
8秒前
香香香发布了新的文献求助10
8秒前
9秒前
我是老大的应助被lxl采纳,获得10
9秒前
喜悦的秋柔完成签到,获得积分10
10秒前
明理小土豆完成签到,获得积分10
11秒前
彭于晏的应助被nicoleJ采纳,获得10
11秒前
无常完成签到,获得积分10
11秒前
HAOYUN驳回了Ava的应助
11秒前
11秒前
吃不饱发布了新的文献求助10
11秒前
11秒前
酷波er的应助被火星猎人采纳,获得10
13秒前
浅唱夏末发布了新的文献求助10
13秒前
黑米粥发布了新的文献求助200
13秒前
13秒前
FashionBoy的应助被尼克采纳,获得10
16秒前
16秒前
16秒前
Mhh发布了新的文献求助10
17秒前
17秒前
领导范儿的应助被dde采纳,获得10
17秒前
笑然发布了新的文献求助10
19秒前
982289172发布了新的文献求助10
19秒前
大宝宝完成签到 ,获得积分10
19秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8187572
求助须知:如何正确求助?哪些是违规求助? 9575676
关于积分的说明 21842241
捐赠科研通 7785368
什么是DOI,文献DOI怎么找? 3435022
关于科研通互助平台的介绍 2559428
邀请新用户注册赠送积分活动 2481917